Ratings by B.Riley (William Wood)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/5/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
1.93 (1.51) |
-21.76% | Details | |
| 5/22/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
2.05 (2.96) |
44.39% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
14.76 (5.00) |
-66.12% | Details | |
| 1/9/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
2.02 (1.97) |
-2.48% | Details | |
| 12/7/2025 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
2.01 (1.68) |
-16.42% | Details | |
| 9/2/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.46 (14.78) |
912.33% | Details | |
| 8/8/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
1.33 (2.81) |
111.28% | Details | |
| 3/12/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.30 (4.43) |
92.61% | Details | |
| 12/1/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
5.76 (17.88) |
210.42% | Details | |
| 12/1/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
7.70 (4.73) |
-38.57% | Details |
